Dr. med. Dr. rer. nat. Yizhu Li

since 2022
Junior group leader
Research group „Translational DNA damage modification"

since 2020
Resident, Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar der TU München

2017 – 2020
Dr. rer. nat. promotion
Doctoral studies "Molecular Medicine" at the University Medical Center Göttingen, topic: "Specific targeting of rapidly dividing cancer cells using cyclotherapy and click-chemistry in vivo" (magna cum laude), supervisor: Prof. Dr. Matthias Dobbelstein

2019
Approbation as medical doctor

2017
Dr. med. promotion
Topic: "Inhibition of the kinase Wee1 - Cytotoxic mechanisms and autoprotection by the tumor suppressor p53" (magna cum laude), supervisor: Prof. Dr. Matthias Dobbelstein

2013 – 2019
Medical studies at the Georg-August University Göttingen

2010 – 2013
Postgraduate studies Molecular Biosciences / Developmental Biology (Master of Science), Ruprecht-Karls-University Heidelberg

2007 – 2010
Basic studies in biology (Bachelor of Science), Christian-Albrechts-University Kiel

> PubMed